By Erin Marie Daly (August 22, 2008, 12:00 AM EDT) -- Plaintiffs lawyers are already taking legal action in the wake of the U.S. Food and Drug Administration's announcement Monday that stronger warnings will be added to the label of Amylin Pharmaceuticals Inc.'s Byetta after reports of two deaths linked to the injectable diabetes medication.
The FDA's heightened safety warning came after the agency said it had received reports of six cases of severe pancreatitis in patients taking Byetta — a drug given by injection twice a day to adults with Type 2 diabetes — and was working with Amylin to add stronger and more prominent warnings to the product label....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!